|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 02801836.4 (espacenet) (Federated) (European Patent Register), 20021022 | | Patent/reg. no. and date | DK/EP 1441701, 20080213 | | Publication date | 20040804 | | Priority no. and date | US 339549 P, 20011026 | | EP pub. no. and date |
EP 1441701 20040804 | | Effective date | | | Applicant/owner | Merck Canada Inc., 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA | | Applicant ref. no. | P1835DKEP | | Inventor | DOWN, Brian, 16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1, CA | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A61K 9/16 (2006.01) | | Title | Montelukast-granuleformulering | | Int. application no. | CA2002001604 | | Int. publication no. | WO2003035036 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
